Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs

Author： Sumner B. Cruise L. Slattery D. Hill D. Shahid M. Henry B.

ISSN： 0033-3158

Source： Psychopharmacology, Vol.171, Iss.3, 2004-01, pp. : 306-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Changes in c-fos expression in the rat heart during morphine withdrawal. Involvement of α₂-adrenoceptors

By González-Cuello Ana Milanés M. Aviles Manuel Laorden M.

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 370, Iss. 1, 2004-07 ,pp. : 17-25

Springer Publishing Company

Access to resources Recommend Favorite

Magnesium Sulphate Attenuates Tourniquet-induced Hypertension and Spinal c-fos mRNA Expression: a Comparison with Ketamine

By Lee DH Jee DL Kim SY Kim JM Lee HM

The Journal of International Medical Research, Vol. 34, Iss. 6, 2006-11 ,pp. : 573-584

Field House Publishing

Access to resources Recommend Favorite

Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine

By Fujimura M. Hashimoto K. Yamagami K.

European Journal of Pharmacology, Vol. 398, Iss. 1, 2000-06 ,pp. : 1-10

Elsevier

Access to resources Recommend Favorite

Hypo- and Hypersalivation Induced by Psychoactive Drugs: Incidence, Mechanisms and Therapeutic Implications

By Szabadi E. Tavernor S.

CNS Drugs, Vol. 11, Iss. 6, 1999-06 ,pp. : 449-466

Adis International

Access to resources Recommend Favorite

Expression Profiling of the Ephrin (EFN) and Eph Receptor (EPH) Family of Genes in Atherosclerosis-related Human Cells

By Sakamoto A Sugamoto Y Tokunaga Y Yoshimuta T Hayashi K Konno T Kawashiri MA Takeda Y Yamagishi M

The Journal of International Medical Research, Vol. 39, Iss. 2, 2011-03 ,pp. : 522-527

Field House Publishing

Access to resources Recommend Favorite